SprintRay used its 3DNext 2026 event to introduce a product family linking the beginning and end of a digital dental case. Foundation is the company's first intraoral scanner. The Nano Series combines NanoPrint, NanoWash and NanoCure. SprintRay says the complete print-wash-cure chain occupies less than 30 inches, or about 72 cm, of counter space.

The announcement, architecture and planned November 2026 shipping window are verifiable. More than 16 indications, a six-minute wash-and-dry cycle and rapid curing are manufacturer performance claims. They are meaningful only for the specified material, software, part, region and instructions for use.

From scanning to a finished restoration

The wireless Foundation captures full-colour intraoral data and transfers a case into the ScanOS cloud service, from which it can connect to design and manufacturing. SprintRay cites more than 20 million produced parts and says over 80% of chairside jobs follow a one-patient, one-case pattern. Those are company platform figures without an independent audit.

NanoPrint uses 385 nm projection and is designed around one-case production. NanoWash washes and dries on the build platform in a sealed cycle, while NanoCure combines two wavelengths with preheating. Compactness may benefit a clinic, but physical proximity does not automatically close the quality chain.

Validation belongs to the combination

For a dental end product, scanner, design software, file revision, printer, layer height, orientation, resin lot, solvent condition, drying and post-cure collectively define the finished device. 'SprintRay validated' does not authorise every machine, country and indication combination.

In a separate partnership, GC America and SprintRay connect the light-cured GC GRADIA PREMi composite with the Midas Digital Press workflow, targeting November 2026 introduction. The product page names definitive restorations, but regional labelling and instructions for use control the actual indication. 'Coming November' is not a regulatory clearance number or a country-specific authorisation.

What chairside adoption requires

Before installation, the clinic should define the approved material-printer-wash-cure combination, accountable role and release criteria for each case type. A representative trial should verify scan completeness, margins, fit, dimensions, surface, cleanliness and post-cure. Automated transfer does not remove risks from poor preparation, incomplete scans or a wrong indication.

Solvent loading, chamber temperature and light-source output need time-based monitoring. A six-minute cycle is acceptable only when the material documentation permits it and finished-part cleanliness is demonstrated. Speed cannot override drying, cure or biocompatibility requirements.

Availability and open questions

SprintRay plans US-first availability for Foundation. It names the United States, Canada, Australia, New Zealand and the European Union for Nano, subject to regulatory conditions; NanoWash is excluded from the stated Canadian offering. Final pricing, service, data terms and regional product status require separate verification.

Editorial conclusion

The central development is not a smaller printer but tighter coupling of case data, production and post-processing. That may reduce hand-off errors and counter-space demand. Clinical value still depends on a regionally authorised, version-controlled combination, demonstrated clinic capability and documented release.

Sources

- SprintRay: Nano Series, Foundation and ScanOS — primary product announcement, 13 October 2026. - GC America: GC GRADIA PREMi and SprintRay partnership — primary material and launch information. - 3D Printing Industry: SprintRay launches chairside workflow — trade-press detector, 21 October 2026.